₹6,712.15
+48.25 (+0.72%)
As of 23 Sept 2026, Astrazeneca Pharma India Ltd share price is ₹6,712.15. The stock opened at ₹6,712.15 and had closed at ₹6,663.90 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹6,606.30 and a high of ₹9,850.00. In terms of performance, Astrazeneca Pharma India Ltd share price has decreased by 19.03% over the past six months and has decreased by 23.77% over the last year.
ASTRAZEN Stock Price Chart
Astrazeneca Pharma India Ltd Overview
Market cap₹16,780 Crs
Volume342
Prev. Close₹6,663.90
Year range₹6,606.30 - ₹9,850.00
ISININE203A01020
About ASTRAZEN
Astrazeneca Pharma India is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and also provides clinical trial services to an overseas group company.
Astrazeneca Pharma India Ltd Historical Performance
1 Month Return-9.42%
6 Month Return-17.69%
3 Year Return46.31%
3 Month Return-21.56%
1 Year Return-24.22%
5 Year Return117.64%
Astrazeneca Pharma India Ltd Fundamentals
ROCE(TTM)25.53%
P/E Ratio (TTM)98.93
P/B Ratio19.23
Debt to Equity0.13
ROE21.49%
EPS (TTM)69.39
Dividend Yield0.54%
Book Value349.12
Profit Margin7.13%
Operating Margin8.74%
Astrazeneca Pharma India Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 2,304.07 | 1,756.92 | 1,330.33 | 1,029.07 | 820.36 |
| EBITDA | 285.27 | 197.81 | 235.68 | 150.99 | 100.94 |
| Net Profit | 187.52 | 115.74 | 161.51 | 99.29 | 61.59 |
| EPS | 75.01 | 46.30 | 64.60 | 39.72 | 24.64 |
Astrazeneca Pharma India Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 6,597.27 |
| Resistance 1 (R1) | 6,757.27 |
| Pivot Point | 6,690.63 |
Astrazeneca Pharma India Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 31-Jul-2026 | 26-May-2026 | 31-Jul-2026 | Final | ₹36.00 |
| 18-Jul-2025 | 30-May-2025 | 18-Jul-2025 | Final | ₹32.00 |
| 05-Jul-2024 | 27-May-2024 | 05-Jul-2024 | Final | ₹24.00 |
| 14-Jul-2023 | 30-May-2023 | 14-Jul-2023 | Final | ₹16.00 |
| 07-Jul-2022 | 26-May-2022 | 08-Jul-2022 | Final | ₹8.00 |
ASTRAZEN Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| Shilpa Divekar Nirula | Chairman |
| Praveen Rao Akkinepally | Managing Director |
| Bhavana Agrawal | Whole Time Director |
Astrazeneca Pharma India Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,846.40-1.20% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,352.00-0.62% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,935.00-0.70% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Astrazeneca Pharma India Ltd today is ₹6,712.15 on NSE and ₹6,712.15 on BSE.
- The 52-week high of Astrazeneca Pharma India Ltd is ₹9,850.00, while the 52-week low is ₹6,606.30.
- The current market capitalisation of Astrazeneca Pharma India Ltd is approximately ₹16,780 crore.
- The P/E (Price-to-Earnings) ratio of Astrazeneca Pharma India Ltd is 98.93. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Astrazeneca Pharma India Ltd is 19.23. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Astrazeneca Pharma India Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for ASTRAZEN on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Astrazeneca Pharma India Ltd has delivered a return of approximately 46.31%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Astrazeneca Pharma India Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 75.00% promoters, -3.32% FIIs, 6.08% DIIs, and 13.76% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
